Understanding how T cells contribute to complications after stem cell transplants
Mechanisms and consequences of T cell inflammasome activation in Graft-Versus Host Disease
This study is looking at how certain immune cells called T cells behave after a stem cell transplant and how they might contribute to a condition called Graft Versus Host Disease (GVHD), with the goal of finding better ways to prevent or treat this serious complication for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Loyola University Chicago NIH-funded |
| Lab location | 1 site (Maywood, United States) |
| Project ID | NIH-10684330 on NIH RePORTER |
What this research studies
This research investigates the role of T cells in Graft Versus Host Disease (GVHD), a serious complication that can occur after hematopoietic cell transplants. The study focuses on how donor CD8 T cells become activated and the mechanisms that prevent their death, which may worsen GVHD. By examining the activation of specific proteins and pathways in these T cells, the researchers aim to uncover ways to mitigate GVHD and improve patient outcomes. Patients may benefit from insights that could lead to new treatments or preventive strategies for GVHD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are receiving hematopoietic cell transplants for conditions such as cancers or genetic immunodeficiencies.
Not a fit: Patients who are not undergoing hematopoietic cell transplants or those with conditions unrelated to GVHD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients undergoing stem cell transplants, reducing the incidence and severity of GVHD.
How similar studies have performed: Previous research has shown that targeting T cell activation pathways can lead to improved outcomes in GVHD, suggesting that this approach may yield valuable insights.
Where this research is happening
Maywood, United States
- Loyola University Chicago — Maywood, United States (Active)
Researchers
- Principal investigator: Campbell, Edward M — Loyola University Chicago
- Study coordinator: Campbell, Edward M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.